Aclaris Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	31.25	29.75	6.76	6.48	4.23	6.15	1.68	0	0	0	Upgrade
Revenue Growth (YoY)	5.03%	340.05%	4.30%	53.35%	-31.28%	265.48%	-	-	-	-	Upgrade
Cost of Revenue	18.08	11.96	4.71	5.13	4.06	4.33	1.21	0	0	0	Upgrade
Gross Profit	13.17	17.79	2.05	1.35	0.17	1.82	0.48	0	0	0	Upgrade
Selling, General & Admin	32.41	25.13	23.62	20.53	27.83	25.76	19.03	15.09	5.33	2.03	Upgrade
Research & Development	98.38	77.81	43.81	29.34	64.17	60.84	35.8	33.48	15.34	6.51	Upgrade
Other Operating Expenses	6.63	0	0	0	18.5	0	0	0	0	0	Upgrade
Operating Expenses	137.43	102.95	67.43	49.87	110.5	86.6	54.84	48.57	20.67	8.53	Upgrade
Operating Income	-124.26	-85.15	-65.38	-48.52	-110.32	-84.78	-54.36	-48.57	-20.67	-8.53	Upgrade
Other Expense / Income	-35.41	1.75	25.48	2.68	51.03	47.96	15.99	-0.49	-0.1	-0.02	Upgrade
Pretax Income	-88.85	-86.91	-90.87	-51.2	-161.35	-132.74	-70.35	-48.08	-20.56	-8.52	Upgrade
Income Tax	-0.37	0	0	-0.18	0	0	-1.83	0	0	0	Upgrade
Net Income	-88.48	-86.91	-90.87	-51.02	-161.35	-132.74	-68.52	-48.08	-20.56	-8.52	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	0	2.57	2.05	Upgrade
Net Income Common	-88.48	-86.91	-90.87	-51.02	-161.35	-132.74	-68.52	-48.08	-23.13	-10.57	Upgrade
Shares Outstanding (Basic)	70	65	57	43	41	33	28	21	6	2	Upgrade
Shares Outstanding (Diluted)	70	65	57	43	41	33	28	21	6	2	Upgrade
Shares Change	7.05%	14.95%	33.36%	2.94%	25.57%	17.11%	31.22%	250.67%	255.04%	59.07%	Upgrade
EPS (Basic)	-1.27	-1.33	-1.60	-1.20	-3.90	-4.03	-2.44	-2.25	-3.79	-6.15	Upgrade
EPS (Diluted)	-1.27	-1.33	-1.60	-1.20	-3.90	-4.03	-2.44	-2.25	-3.79	-6.15	Upgrade
Free Cash Flow	-79.63	-68.17	-52.44	-39.09	-98.06	-102.17	-55.9	-34.84	-20.88	-8.05	Upgrade
Free Cash Flow Per Share	-1.14	-1.04	-0.92	-0.92	-2.37	-3.10	-1.99	-1.63	-3.42	-4.68	Upgrade
Gross Margin	42.14%	59.80%	30.29%	20.81%	4.07%	29.62%	28.28%	-	-	-	Upgrade
Operating Margin	-397.64%	-286.21%	-967.08%	-748.52%	-2609.98%	-1378.31%	-3230.01%	-	-	-	Upgrade
Profit Margin	-283.15%	-292.11%	-1343.96%	-787.03%	-3817.22%	-2157.99%	-4071.48%	-	-	-	Upgrade
Free Cash Flow Margin	-254.84%	-229.13%	-775.65%	-602.99%	-2319.80%	-1660.98%	-3321.33%	-	-	-	Upgrade
EBITDA	-87.99	-86.11	-89.94	-49.87	-154.95	-130.86	-69.95	-47.96	-20.47	-8.51	Upgrade
EBITDA Margin	-281.56%	-289.43%	-1330.31%	-769.41%	-3665.60%	-2127.44%	-4156.33%	-	-	-	Upgrade
Depreciation & Amortization	0.86	0.8	0.92	1.32	6.41	1.88	0.4	0.12	0.09	0.01	Upgrade
EBIT	-88.85	-86.91	-90.87	-51.2	-161.35	-132.74	-70.35	-48.08	-20.56	-8.52	Upgrade
EBIT Margin	-284.32%	-292.11%	-1343.96%	-789.83%	-3817.22%	-2157.99%	-4180.21%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).